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A B S T R A C T
Surfactin has potential as next generation antibiofilm agent to combat antimicrobial resistance against
emerging pathogens. However, the widespread industrial applications of surfactin is hampered by its
high production cost. In this work, surfactin was produced from Bacillus subtilis using a low-cost brewery
waste as a carbon source. The strain produced 210.11 mg L1 after 28 h. The antimicrobial activity was
observed against all tested strains, achieving complete inhibition for Pseudomonas aeruginosa, at
500 mg mL1. A growth log reduction of 3.91 was achieved for P. aeruginosa while, Staphylococcus aureus
and Staphylococcus epidermidis showed between 1 and 2 log reductions. In the anti-biofilm assays against
P. aeruginosa, the co-incubation, anti-adhesive and disruption showed inhibition, where the greatest
inhibition was observed in the co-incubation assay (79.80%). This study provides evidence that surfactin
produced from a low-cost substrate can be a promising biocide due to its antimicrobial and anti-biofilm
abilities against pathogens.
© 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Control of pathogenic microorganisms is essential for human
health maintenance since they are responsible for several
infectious diseases. Furthermore, the indiscriminate use of anti-
biotics in the past few decades has led to the selection of
multiresistant microbial strains to traditional antibiotics, reducing
the ability to treat diseases and enhancing the search for new
compounds to improve the management of bacterial infections
[1,2].
Bacteria colonization is often influenced by quorum sensing
(QS), a mechanism, responsible for their ability to communicate
with each other and to behave as a population. This phenomenon is
fundamental for biofilm formation, in which the bacteria remains
protected from environmental risks in a self-produced extracellu-
lar matrix, with high tolerance to chemical and physical treatments
than planktonic cells forms [3,4].
The presence of biofilms may cause serious problems in the
field of medicine and food industry. In hospitals, biofilms may
result infections in patients with internal medical devices, such as
urinary, endotracheal, intravenous, and other types of catheters
and implants inserted into over 25% of patients during hospitali-
zation [5,6]. In food industry, biofilms present on equipment or any
related devices in direct contact with food will become a source of
contamination, representing a risk to consumers through the
transmission of diseases, as well as causing economic losses [7].
In this regard, the search for novel natural compounds with
biocidal activity against pathogenic microorganisms is an urgent
requirement. Biosurfactants are compounds capable of reducing
the surface tension of liquid phases in contact with gas, or
interfacial tension between immiscible liquids. The ability to
reduce the surface/interfacial tension is due to the characteristics
of the surfactant molecules, which have a hydrophilic and a
hydrophobic moiety [8]. They can also interfere in biofilm
development and communication between the cells and may
cause rupture of membranes, causing cell lysis, and disruption of
the surface properties affecting the adherence of the micro-
organisms [9].
Previous studies have shown the ability of different types of
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ith biosurfactant and 65% of biofilm disruption after treatment.
n a similar investigation, Díaz De Rienzo et al. [11] reported the
ntimicrobial and biofilm disruption of Cupriavidus necator ATCC
7699 and Bacillus subtilis BBK006 using sophorolipids (5%, v/v).
Lipopeptides are the mostly widely known biosurfactants with
ntimicrobial activity, where surfactin produced by Bacillus
irculans is the most prominent antimicrobial lipopeptide [12].
owever, most studies reported in the literature present qualita-
ive data, obtained mainly by using antimicrobial sensitivity tests
disk diffusion method). The mixture of lipopeptides (surfactin,
turin and fengycin) from B. subtilis showed significant anti-
dhesive and antibiofilm activities on uropathogenic bacteria [13].
he effect of surfactin on adhesion and biofilm formation was
valuated by de Araujo et al. [7], in which the biosurfactant
ignificantly reduced adhesion of Pseudomonas fluorescens ATCC
3525 on polystyrene surfaces (54% of inhibition) and a biofilm
ormation (73%) on stainless steel surfaces.
Considering, the properties of surfactin as antimicrobial and
ntibiofilm agent, there is much scope for their potential
pplication in biomedicine. Although, the major hurdle in the
idespread applications of surfactin is its high production cost.
he production of biosurfactants depends on abundance
nd low substrate cost since it represents 30–50% of the value
f the final product [14]. In relation to substrate costs, the use of
gro-industrial waste in fermentation processes becomes an
ttractive alternative for the production of biosurfactants, since
hese residues often have favorable compounds for such
rocesses, being a source of carbohydrates, protein, and
icronutrients [14].
This work aimed to explore the application of biosurfactant,
roduced from a low-cost substrate, as antimicrobial and
ntibiofilm agent. B. subtilis ATCC 6051 produced biosurfactant
sing a brewery waste (Trub) as a substrate, where the chemical
omposition of the biosurfactant was investigated by MALDI-ToF-
S and FTIR analysis. The antimicrobial and anti-biofilm (co-
ncubation, anti-adhesive and disruption) activity of biosurfactant
gainst several different pathogenic strains was further investi-
ated. This work demonstrated the potential antimicrobial and
ntibiofilm of biosurfactant, being an interesting tool for food and
edical field. In addition, it was possible to provide a suitable
estination for the brewery waste, making the beer industry more
ompetitive and contributing to the environment preservation.
. Materials and methods
.1. Microorganisms
B. subtilis ATCC 6051 was used for biosurfactant production and
urchased from the Culture Collection of the Tropical Foundation
or Research and Technology André Tosello (Campinas, SP, Brazil).
seudomonas aeruginosa DSM 3227, Escherichia coli ATCC 25922,
taphylococcus aureus DSM 20231 and Staphylococcus epidermidis
SM 28319 were used in the antimicrobial and antibiofilm assays.
The strains were stored in (1:1) Nutrient Broth medium (NB)
with 20% glycerol at 80 C. Whenever required, the frozen stocks
of cells were streaked in plates with Nutrient Agar medium (NA)
and incubated for 24 h at 37 C. After incubation, the working
stocks were kept at 4 C.
2.2. Media composition and culture conditions of biosurfactant
production
The carbon source used in the medium was Trub, which is a
brewery waste resulting from the baking stage of the must and it
was kindly provided by Kairós Brewery (Florianópolis, SC, Brazil).
The Trub was characterized by Elemental Analysis and Enzymatic-
Colorimetric Method. The results are shown in Table 1.
Biosurfactant production was carried out at 30 C in a culture
medium adapted from Maass et al. [15], composed of 2% (v/v) of
Trub, 0.1 g L1 of CaCl2, 0.1 g L
1 of NaCl, 0.33 g L1 of FeSO47H2O,
0.0017 g L1 of MnSO4H2O, 1.69 g L1 of KH2PO4, 0.50 g L1 of
MgSO47H2O, 0.90 g L1 of peptone and 7.0 g L1 of yeast extract.
The pH of the medium was adjusted to 7.0 prior to sterilization at
121 C for 20 min. The inoculum of B. subtilis ATCC 6051 was
prepared by adding 2 mL of an overnight culture into 50 mL of NB,
being subsequently incubated for 24 h at 30 C. After incubation,
the inoculum was standardized by adjusting its absorbance at
600 nm to 0.85 and added to the culture medium in a concentra-
tion of 5% (v/v). The flasks were incubated on a rotary shaker at
200 rpm for up to 28 h.
2.3. Recovery of biosurfactant
The biosurfactant was recovered by centrifuging (9000 rpm,
20 min) the culture broth in order to remove suspended solids
(cells and solid particles from Trub). Subsequently, the pH of the
supernatant was adjusted to 2.0 by adding HCl (4.0 M) and left
overnight under refrigeration (4 C) for precipitate formation [16–
18]. The precipitated biosurfactant was centrifuged, washed twice
with acidified water (pH 2.0) and resuspended in Milli-Q1 water
(Millipore, USA). The pH of the solution was adjusted to 7.0,
lyophilized, weighed and stored at 18 C [15].
2.4. Determination of surface tension
A digital tensiometer (KSV, Sigma 702, Finland) was used for
measure the surface tension of the cell-free supernatant by the
Wilhelmy platinum plate method. Measurements were performed
in triplicate at 25 C. The critical micelle concentration (CMC) of the
biosurfactant was determined by surface tension measurements of
successive dilutions of aqueous biosurfactant solution, according
to the methodology proposed by Sheppard and Mulligan [19].
2.5. Structural characterization of biosurfactant
The biosurfactant was chemically characterized by Matrix
assisted laser desorption ionization time-of-flight mass
able 1
hysico-chemical characterization of the Trub.
Concentration g L1
  MethodTOC 31.50 Total Organic Carbon Analyzer (TOC – SHIMADZU)
TC 31.91
IC 0.41
TN 3.45 Enzymatic-Colorimetric (Kit Gold Analisa Diagnostics)
pH 5.73
OC: total organic carbon, TC: total carbon, IC: inorganic carbon, TN: total nitrogen.
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Voyager-DE Biospectrometer (Hertfordshire, UK) equipped with a
1 m time-of-flight tube. The system utilized a pulsed nitrogen laser
set at 337 nm towards the densest area of the sample/matrix spot.
The accelerating voltage was maintained at 20,000 V, the grid
voltage and guide wire voltages were set at 93% and 0.05%
respectively of the accelerating voltage. A solution of alpha-cyano-
4-hydroxycinnamic acid (CHCA) matrix (Sigma Aldrich, UK) with a
concentration of 10 mg mL1 was prepared in 80% acetonitrile, 20%
water with 0.1% trifluroacetic acid. 10 mL aliquot of sample was
mixed with 10 mL of matrix and, subsequently, the samples were
spotted on MALDI plate for analysis.
The functional groups and the chemical bonds present in the
biosurfactant were analyzed using the Fourier transform infrared
spectroscopy (FTIR) technique, using a Cary 660 Series FTIR
Spectrometer – Agilent Technologies. For the analysis, a small
sample of the dry bioproduct was mixed with potassium bromide
(KBr). The FTIR spectrum was generated from 400–4000 cm1.
2.6. Investigation of the antimicrobial activity of biosurfactant
The antimicrobial activity of biosurfactant was carried out in
96-well microtiter plates (Sarstedt), in which different concen-
trations of biosurfactant dissolved in Mueller Hinton broth (MHB)
were evaluated: P. aeruginosa (500-100 mg mL1), S. aureus (800–
50 mg mL1), E. coli (800–50 mg mL1) and S. epidermidis (800–
100 mg mL1).
In columns 1–10, 50 mL of biosurfactant in MHB were
inoculated with 50 mL of selected microorganism, achieving a
concentration per well of 5  105 CFU mL1. The inoculum was
standardized by adjusting OD600 to a value corresponding to
108 CFU mL1. In the last two columns of the 96 well-plate, a
growth control (broth with bacterial inoculum) and a sterility
control (broth only) were established [20,21].
The well-plates were incubated at 37 C for 24 h and serial
dilutions were performed. 20 mL from the serial dilution of each
biosurfactant concentration was dispensed in Mueller Hinton Agar
(MHA) and incubated at 37 C to obtain the CFU by Drop plate
method [22,23]. All the concentrations were tested in triplicate and
a CFULog10 reduction after biosurfactant treatment were evaluated
according to the equation:
Log reduction ¼ log10A  log10B;
where A is the CFU mL1 of growth control and B is the CFU mL1
after biosurfactant treatment.
2.7. Investigation of the antibiofilm activity of biosurfactant
The biofilm formation ability of P. aeruginosa was evaluated
according to O’Toole [24] and, in all the experiments, the
absorbance of inoculum at 600 nm corresponded to a value
equivalent to 108 CFU mL1. The tests were performed on
polystyrene-24-well plate (Sarstedt) and untreated wells were
used as controls.
The potential of the biosurfactant to prevent a biofilm
formation was studied using two different techniques: co-
incubation and anti-adhesive. In the co-incubation experiments,
development due to the co-incubation of the strain with the
biosurfactant.
The anti-adhesive activity was tested by pre-coating the wells
with solutions of biosurfactant prepared in Phosphate buffered
saline – PBS (250–500 mg mL1) in which 1 mL of each concentra-
tion was dispensed in the corresponding well and incubated for
24 h at 40 C in order to improve the adsorption. After the
adsorption time had elapsed, the plate contents were removed,
and the wells were washed twice with PBS to removed unbound
biosurfactant. The plate was sterilized for 3 h under UV light and
1 mL of standardized culture was added followed by incubation for
24 h at 37 C.
The antibiofilm activity was also explored in the ability of the
biosurfactant to disrupt an existing biofilm [25]. Initially, 1 mL of
standardized culture was added in each well and the plate was
incubated for 24 h at 37 C for the biofilm development. After the
incubation period, the planktonic cells were discarded, and the
biofilm was washed twice with PBS. 1 mL of fresh media with
different concentrations (200–700 mg mL1) of biosurfactant was
added and incubated for 24 h at 37 C.
At the end of all experiments, the plates contents were
discarded, and the wells were washed twice with PBS to remove
planktonic cells before staining the biomass attached to the surface
of the wells. The plates were stained with crystal violet (0.1%) for
15 min at room temperature. Posteriorly, the plates were washed
twice with sterilized water and left to dry overnight. One mL of
acetic acid (30%, v/v) was added in each well and the absorbance of
the content of the well was measured at 575 nm [24].
The percentage of the biofilm inhibition was calculated using
the following equation,
Biofilm inhibition ð%Þ ¼ 100  ODC  ODtð Þ=ODC;
where ODc and ODt correspond to the optical density of the
untreated biofilm and treated biofilm with biosurfactant, respec-
tively.
2.8. Images
Scanning electron microscope (SEM) was employed to investi-
gate the biofilm of P. aeruginosa. The control and biofilm assays (co-
incubation, anti-adhesive and disruption) were carried out on
coverslip as the adhering surface at 450 mg mL1 surfactin
concentration. At the end of each experiment, the coverslips were
washed with PBS and immersed in 2.5% glutaraldehyde solution
for 12 h. After that, the cells were dehydrated in graded ethanol
(50%, 65%, 80%, 95% and 100% v/v) during 10 min and in
hexamethyldisilazane (HMDS) in ratios of (1:1), (1:2), (1:3) and
100%, during 15 minutes each. The HMDS evaporated overnight
and the samples were coated and analyzed under SEM [11].
2.9. Statistical analysis
The results were expressed as the mean  SD (standard
deviation) of 3 independent replicates. The data were analyzed
using ANOVA (Analysis of variance), and the means were compared
with the Duncan's test (5% probability). Significance of variances is
indicated as follows: NS (Non-significant), *p < 0:05, **p < 0:05,
***p < 0:005.1 mL of a range of biosurfactant concentrations (250–
500 mg mL1) dissolved in NB was inoculated (5%, v/v) followed
by incubation for 24 h at 37 C. After the incubation time, the
biofilm formed in Control wells and in the wells treated with
surfactin were quantified by Crystal violet according to O’Toole
[24]. This assay aimed to evaluated the inhibition of biofilm3
3. Results and discussion
3.1. Biosurfactant production and characterization
Previous studies reported surfactin production using different
medium composition, as mineral salt medium (MSM) with
c
e
p
s
i
y
f
a
p
l
W
c
s
fi
p
s
w
m
m
c
B
(
a
a
e
r
i
s
a
p
w
s
a
b
r
i
m
(
(
w
r
F
1
T.C. Nazareth, C.P. Zanutto, L. Tripathi et al. Biotechnology Reports 28 (2020) e00537arbohydrate or nitrogen sources [26] and MSM plus trace
lements [27]. However, due to their low yield and a high
roduction cost, biosurfactant are unable to compete with the
ynthetic surfactant. Regarding this, a low cost production medium
s important to minimize the production cost and achieve high
ields. An alternative towards the commercialization of biosur-
actants can be the use of cheap raw materials including
gricultural and industrial wastes. For the first time, the
roduction of surfactin was performed in culture medium using
ow-cost brewery residue (Trub) in a shake-flask fermentation.
ithin 28 h, the strain was able to reduce the surface tension of the
ulture medium from 54 to 28 mN m1. At the end of the batch, the
urfactin concentration obtained was 210.11  0.85 mg L1, con-
rming that Trub is a potential substrate for biosurfactant
roduction.
Renewable resources have been used as carbon source in
urfactin production as described by Ponte Rocha et al. [28], in
hich B. subtilis LAMI008 produced biosurfactant in mineral
edium containing clarified cashew apple juice. When the
edium was supplemented with yeast extract, the surfactin
oncentration was 3.5 mg L1.
Moya Ramírez et al. [29] evaluated surfactin production by
acillus sp. using medium containing 2% (w/v) of Olive mil waste
OMW), achieving a maximum concentration of 3.12 mg L1 after
pproximately 6 days of fermentation. The following year, the
uthors proposed a pre-treatment of the residue, proving that the
nzymatic hydrolysis of OMW favored surfactin production,
eaching a maximum concentration of 26.5 mg textrmL1 [30].
Efficient spectroscopic techniques have been utilized for
nvestigations on the biochemical structure of biosurfactants,
uch as MALDI-ToF mass spectrometry and FTIR spectroscopy
nalysis. The MALDI-ToF mass spectrum revealed the
resence of masses very similar to lipopeptide compounds, in
hich most of peaks could be attributed to the isoform of
urfactins (Fig. 1). The peak at m=z ¼ 1074:6 was clearly the most
bundant in the spectrum followed by peak at m=z ¼ 1058:6 and
oth correspond to potassium and sodium adducts of surfactin C15,
espectively. In addition, the following peaks with higher
Surfactin is able to disturb the membrane stability due to its
interaction with the cell membrane [35]. According to Liu et al.
[36], among the surfactin isorforms such as surfactin C13, surfactin
C14 and surfactin C15, surfactin C15 was the most effective
compound to interact with membranes due to the greater fatty
acid chain inducing a greater interfacial activity of surfactins with
the membrane. Iturin peaks, at negligible intensities, were also
detected from the MALDI-Tof-MS (Fig. 1) analysis: Iturin C16
(m=z ¼ 1092:58), Iturin C17 (m=z ¼ 1084:56), Iturin C18
(m=z ¼ 1098:57), and Iturin C19 (m=z ¼ 1112:57) [31]. The
concentration of Iturin was too low, suggesting it has no
contribution to antimicrobial activity. In addition, no peaks of
Fengycin were detected in the spectrum even Maldi-Tof-MS being a
quite sensitive technique that allows detecting small amounts.
The FTIR spectra (Fig. 2) shows the lipopeptide nature of the
biosurfactant since the main characteristic groups of surfactin
molecule, such as aliphatic hydrocarbon and peptide-like moiety,
are presented [37]. The peaks highlighted in Fig. 2 are the same
presented for standard surfactin (Sigma–Aldrich, 98% purity),
reported by Sousa et al. [37]. According to Joshi et al. [38], the
bands at 3300–3400 cm1 and 1650–1700 cm1 (stretching mode
of the CON bond) are characteristic of peptides. Absorbance in
this region (3300–3400 cm1) occurred due to CH and NH
ig. 1. MALDI-ToF-MS spectrum in positive mode of biosurfactant from B. subtilis ATCC 6051. The spectrum shown data for surfactin C16 (1088.6), surfactin C15 (1036.6,
058.6, 1060.6, 1074.6), surfactin C14 (1022.6, 1044.6), surfactin C13 (1008.6, 1016.6, 1030.6, 1032.6, 1046.6) and surfactin C12 (994.6).Fig. 2. Fourier transforms infrared spectrum of biosurfactants synthesized by B.
subtilis ATCC 6051 using Trub as a carbon source.ntensities refer to surfactin C13, with mass numbers of
=z ¼ 1008:6, 1030.6, 1046.6. The presence of surfactin C16
m=z ¼ 1088:6), surfactin C14 (m=z ¼ 1022:6) and surfactin C12
m=z ¼ 994:6) was also verified. These results are in agreement
ith previous studies, since the authors also compared their
esults with standard surfactin [31–34].4
T.C. Nazareth, C.P. Zanutto, L. Tripathi et al. Biotechnology Reports 28 (2020) e00537stretching vibrations, been also characteristic of carbon-containing
compounds with amino groups. Besides, the presence of intramo-
lecular hydrogen bonding also corresponds to this region [12]. The
aliphatic chains (CH3, CH2) are exposed in the bands at
1200–1400 cm1 [38] and the band at 1729 cm1 is associated to
the absorption of C¼O groups from lactonization [37].
The critical micelle concentration (CMC) is an appropriate indicator
of the biosurfactant efficiencysince biosurfactants with low CMC values
can be considered a good surfactant [39]. The CMC of the biosurfactant
was determined by a plot of ST vs. log of surfactin concentration (Fig. 3),
withavalueof15 mg L1. This value is close to those presented in the
literature, in which Felix et al. [40] presented a CMC of 12.5 mg L1
for surfactin synthesized by B. subtilis using clarified cashew apple
juice as carbon source. In addition, the CMC reported in this work is
also a satisfactory when compared to commercial standard
surfactin (Sigma–Aldrich, 98% purity), whose CMC is between
7.5 and 20 mg L1, depending on methods.
3.2. Antimicrobial activity
The antimicrobial activity of the biosurfactant was tested
against different microorganisms, which the highest inhibition for
P. aeruginosa was achieved using 500 mg mL1 of crude biosur-
factant. At this concentration, the bacteria was completely killed.
This concentration represents the minimum bactericidal concen-
tration (MBC) which is the lowest concentration capable to
eliminate a microorganism, i.e. not revivable under in a fresh
sterile medium [12]. This phenomenon can also be confirmed by
the ratio MBC/MIC, which is 2.5. To ratios 4.0, the agent can be
considered bactericidal [41]. The MIC was determined as the
minimum biosurfactant concentration that inhibited bacterial
growth, which was 200 mg mL1. The treatment with 400 mg mL1
of biosurfactant promoted a Log10 reduction of 3.91  0.23 for P.
aeruginosa (Fig. 4 (a)). This result shows the biocidal nature of
Fig. 3. The surface tension values of different concentrations of the surfactin. The
intercept point represents the estimated CMC concentration.Fig. 4. Antimicrobial activity of different concentrations of biosurfactant (surfactin) against (a) P. aeruginosa; (b) E. coli; (c) S. aureus and (d) S. epidermidis. Values are
represented as means  SD (n ¼ 3).
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ntreated bacteria after 24 h of treatment.
For the gram-positive strains, as S. aureus and S. epidermidis, the
ighest Log10 reduction using 800 mg mL
1 (Fig. 4c and d,
espectively) were 1.70  0.09 and 2.04  0.38, respectively. The
iosurfactant was less effective against E. coli with only 0.57 Log10
eduction at 800 mg mL1 (Fig. 4b). These results were also in
greement with previous findings of Fanaei and Emtiazi [42], in
hich surfactin presented little or no activity against E. coli while
howing inhibitory effect against S. aureus by disc diffusion
ethod.
Santos da Silva et al. [43] evaluated the antimicrobial activity of
urfactin against S. aureus ATCC-6533 and E. coli CCT-0355. The
iosurfactant was produced by Bacillus sp. ITP-001 and the
ntimicrobial activity was determined by measuring zones of
nhibition. While no antimicrobial effects were observed on S.
ureus, a significant inhibition was detected against E. coli at
300 mg L1 [43]. In our study, we have used a microtiter plate
ssay to measure the antimicrobial activity. We could estimate that
he difference in analysis methods could be one of the reasons for
he difference in efficacy of surfactin to the previous report.
Sudarmono et al. [44] reported that surfactin produced by B.
myloliquefaciens presented antimicrobial activity against S. aureus
TCC 25923, P. aeruginosa ATCC 27853 and E. coli ATCC 25922,
howing Inhibition zone diameter of 20.0, 15.7 and 11.4 mm,
espectively. The MIC was determined by resazurin assay in a 96
ell-plate for P. aeruginosa (MIC > 1024 mg mL1). The different
urfactin isoforms could be a reason for the higher MIC compare to
his work since Sudarmono et al. [44] reported the presence of
everal isoforms of surfactin (C12–C16), mainly surfactin C16 and
12.
The biocidal properties of surfactin observed in this work are
ery promising. The surfactin showed potential antimicrobial
ctivity against both Gram-positive and Gram-negative bacteria.
he lipopeptides from surfactin family are b-hydoxy hepta cyclic
epsipeptides with possibilities of Ala, Val, Leu or Ile amino acid
ariations at positions 2, 4, and 7 in cyclic depsipeptide moiety and
13 to C16 variation in b-hydroxy fatty acid chains [32]. The
ariation in the structural composition of surfactin can be the main
eason for antimicrobial activity, since it can significantly influence
he physico-chemical properties and physiological activities,
ncluding interaction with the microbial membrane. The composi-
ion of surfactin is highly dependent on strain, culture condition,
nd growth medium composition [35,44].
Surfactins are mainly composed of C13-surfactin, C14-surfactin,
nd C15-surfactin, and its amphiphilic structural contribute to
nteraction with cell membranes. The C15-surfactin non-competi-
ively inhibits the activity of the alkaline phosphatase due to the
helating action by the free carboxyl groups of the Asp and Glu
esidues. On the other hand, the binding of C15-surfactin with
ipopolysaccharides leads to the interruption of the lipopolysac-
harides-induced pathway, inhibiting its activity [36].
Several studies in the literature evaluate the antimicrobial
ctivity through the agar diffusion tests, which does not allow
ndicating values of concentrations of antimicrobial agents and
heir respective inhibitory effect on microorganism growth
43,45]. In our study, we carried out a throughput assay using
6-well plates, allowing us to evaluate the effect of different
iosurfactant concentrations on the test microorganisms.
and supplementary substances from the cells and allows small
molecules to enter cells and inhibiting their metabolism.
Antimicrobial activity of surfactin is based on permeabilization
of the cell membrane of the microorganisms due to the
accumulation of biosurfactant on the microbial cell, causing its
disintegration through the formation of pores in the cell
membrane, inducing an increase in Ca2þ and Hþ flux in the cells
[48]. Moreover, the activity of surfactin is influenced by the
Fig. 5. Antibiofilm activity of biosurfactant (surfactin) against P. aeruginosa DSM
3227 at different concentrations: (a) co-incubation, (b) anti-adhesive and (c)
disruption. Values are represented as means  SD (n ¼ 3).According to Kaczorek et al. [46], the biosurfactant acts in
ellular phospholipid membrane, which is responsible for protect-
ng their inner plasma membrane and cell wall from external toxic
ompounds [47], causing permeability due to the penetration of
iosurfactant molecules through hydrophobic interactions. This
ermeability leads to a release of small metabolites, ions, enzymes,6
concentration, since the biosurfactant is able to penetrate the
membrane even at low concentrations, owing to the fact it is
miscible with phospholipids, forming mixed micelles. At moderate
concentrations of surfactin, the formation of ion-conducting pores
in the membrane increases and, at high concentrations, the
membrane is ruptured due to the detergency effect [49].
Fig. 6. Scanning electron microscopy images of P. aeruginosa DSM 3227. (a) Control shows biofilm formation after 24 h of incubation. Co-incubation (b), anti-adhesive (c) and
disruption treatment (d and e). Damage in cells and outpouring of cell cytoplasmic is indicated with arrows. For all assays, 450 mg mL1 of biosurfactant were tested for
24 h.
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The antibiofilm activity of crude surfactin was evaluated against
. aeruginosa and performed in three different ways: co-incubation,
nti-adhesive and disruption. Optical density values were signifi-
antly different for the biofilm in the presence of the different
reatments with respect to the control (p < 0:005).
The co-incubation assay was the most efficient, reducing
iofilm formation by 79.80  .91% when using 400 mg mL1
iosurfactant treatment. It is noted that percent inhibition
emained between 72.14  0.78 and 79.29  0.89% for the other
urfactin treatments and this inhibitory effect may have been
aused by the antimicrobial activity of surfactin (Fig. 5a). Such
nhibition of biofilm formation in co-incubation treatment has
een described by Sriram et al. [50], who evaluated the antibiofilm
ctivity of surfactin produced by Bacillus cereus NK1 against P.
eruginosa. This was the only work found by the authors, which
eported surfactin antibiofilm activity when co-incubated with P.
eruginosa. The assay was performed in polystyrene 96 well-plate
ith Brain Heart Infusion broth (BHI) using 0.1–15 mg mL1
iosurfactant concentrations. The highest percentage of inhibition
eported was 54.21  0.04% at 15 mg mL1. It is difficult to compare
esults in the literature, since fermentation for biosurfactants
roduction provides a mixture of homologues, which can present
ifferent percentages of inhibition when used to inhibit biofilm of
he same lineage of microorganisms [51].
To our knowledge, this study is the first reporting surfactin with
nti-adhesion properties against P. aeruginosa biofilm. The anti-
dhesive experiment revealed the highest inhibition of
8.81  2.85% by pre-coating the surface with 350 mg mL1 crude
urfactin (Fig. 5b), suggesting that it is capable to modify the
hysico-chemical properties of the surface reducing adhesion and
nhibiting biofilm formation. Moreover, lipopeptides alter the
ydrophobicity of the bacterial surface and, consequently, alter the
dhesion mechanism of the microorganisms. Its effects depend on
he initial bacterial hydrophobicity, as well as the type of
ipopeptide and its concentration, which may increase or decrease
he hydrophobicity of the bacterial surface due to being more or
ess hydrophobic [52]. The anti-adhesive activity of biosurfactants
as been described in previous reports, in which Janek et al. [53]
resent the ability of Pseudofactin II (0.5 mg mL1), a cyclic
ipopeptide, to prevent biofilm formation on polystyrene surface
f E. coli, Enterococcus faecalis, Enterococcus hirae, S. epidermidis,
roteus mirabilis and Candida albicans. Araujo et al. [7] observed
hat surfactin, at 0.50% (w/v), significantly reduced adhesion of
isteria monocytogenes on polystyrene surfaces when used at
igher concentrations, reaching values of up to 54% inhibition. For,
seudomonas fluorescens, the highest inhibition was only 17.1%.
In this study, the biosurfactant was also employed to disrupt a pre-
xisting biofilm, achieving 44.94  6.19% of inhibition at surfactin
oncentration of 700 mg mL1. The percentage of inhibition
emained similar for treatments between 200 and 500 mg mL1
Fig. 5c). The inhibition may have been induced by the removal of
xtracellular polymeric substances (EPS) and the destruction of
icrocolonies, caused by the biosurfactant [4]. The EPS plays an
mportant role in the biofilm resistance, as it hinders contact of the
icroorganism with the antimicrobial agent [51]. Díaz De Rienzo
t al. [4] pointed out that P. aeruginosa biofilms were disrupted by
1
(450 mg mL1) on biofilm formation and disruption. SEM analysis
showed changes in biofilm morphology and topography as a result
of treatment with the surfactin.
In the co-incubation assay, where cells were treated with
surfactin for 24 h, the inhibition in biofilm formation was visible
with changes in cell morphology observed. This effect was
probably due to the antimicrobial activity of surfactin, which
did not allow the full development of the biofilm. Furthermore,
treated cells appear visually shorter than control cells (Fig. 6b).
Similar observation was also reported by Dengle-Pulate et al. [54],
in which E. coli cells had reduced size after treated with
sophorolipids.
In the anti-adhesive test, the presence of free-living cells, in
planktonic form was observed (Fig. 6c). However, they do not form
a biofilm, suggesting that the coating with biosurfactant was
effective in inhibiting biofilm formation. Similar observation was
reported by Araujo et al. [7], who evaluated anti-adhesion activity
of rhamnolipids (0.50%, w/v) against P. fluorescens, with a higher
percentage of inhibition of 79%. The authors reported the growth of
planktonic cells practically did not differ from the control,
suggesting that biosurfactants do not affect planktonic growth
and are adsorbed to polystyrene surfaces when used as surface
conditioners.
In the rupture test, the biofilm was treated for 24 h with culture
medium containing biosurfactant. After the treatment, regions of
rupture within the biofilm were observed as well as the presence of
cell in monolayers, while in the control the cells were distributed in
multilayers (Fig. 6d). Damage in the cell membrane and outpouring
of cellular cytoplasm after cell disruption is noticeable (Fig. 6e).
4. Conclusions
B. subtilis ATCC 6051 was able to grow in medium containing
brewery residue and produce highly surface-active biosurfactant.
Surfactin inhibited the growth of all microorganisms tested. The
bactericidal effects were highest against P. aeruginosa. In addition,
surfactin was also effective against P. aeruginosa biofilm, present-
ing the highest inhibition (79.80%) in the co-incubation assay,
using a biosurfactant solution at 400 mg mL1. Therefore, the cost-
effective production of surfactin together with antimicrobial and
anti-biofilm activity makes it relevant for biomedical applications.
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